glp-1 receptor agonists effectiveness comparison Agonist Market Size & Analysis, 2026-2033 GLP-1RAs and SGLT2 Inhibitors Show

Women internationally experience delayed diagnosis and dissatisfaction with care (3-5)

Efficacy and safety of Tirzepatide in type 2 diabetes and obesity management

Where it works: Adipose tissue (fat cells): Reduces inflammation and may improve fat metabolism Pancreas: Works alongside GLP-1 to enhance insulin secretion Brain: May contribute to appetite regulation (research ongoing) Weight loss contribution: When GIP is added to GLP-1 (as in tirzepatide), weight loss increases from ~15% to ~22%

However, to date, there is only one randomized clinical trial of GLP-1 RAs (the ELIXA study) evaluating major cardiovascular events as their primary outcomes, and in this study, a neutral cardiovascular effect of lixisenatide was observed in high-risk diabetic subjects

The older AOMs represent less than 3 percent of weight-loss medication costs

Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats